Abstract
A 33 year old man developed acute oliguric failure lasting 66 days, eight days after admission with multiple gun shot wounds. On day 99 after admission, serum calcium was elevated mildly at 2.54 mmol/ 1 (normal range 2.1-2.5 mmol/1). Serum parathormone was undetectable. He was discharged soon afterwards. He presented again on day 164 with nausea, vomiting and blurred vision. Fundoscopy revealed an ischaemic retinopathy and extensive keratopathy. Serum calcium was 3.48 mmol/1 and serum creatinine 262 umol/l (normal range 40-110 umol/l). Repeat parathormone was undetectable and there was no evidence of myeloma, sarcoidosis or malignancy.
Following treatment with intravenous saline and frusemide, serum calcium fell to a nadir of 3.05 mmol/ I. On day 168 an infusion of sodium clodronate 300 mg was given. Twenty-four hours later serum calcium was 2.65 mmol/l and 48 hours later calcium was 2.26 mmol/1. Normocalcaemia was maintained for 17 days and severe hypercalcaemia never recurred.
This is the first report in which biphosphonates have been successfully used to treat hypercalcaemia following acute renal failure thus obviating the need for further dialysis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Feinstein, E. I., Akmal, M., Tefler, N., Massiy, S. G. Delayed hypercalcaemia with acute renal failure associated with non-traumatic rhabdomyolysis. Arch. Lit. Med. 1981: 141, 753–55.
Segal, A. J., Miller, M., Moses, A. M. Hypercalcaemia during the diuretic phase of acute renal failure. Ann. Int. Med. 1986: 68(5) 1066–68.
Leonard, A., Melms.R. J. Jr. Hypercalcaemia in diuretic phase of acute renal failure. Ann. Int. Med. 1970: 73, 137–38.
Koffler, A., Friedler, R. M., Massry, S. G. Acute renal failure due to nontraumatic rhabdomyolysis. Ann. Int. Med. 1976: 85, 23–8.
Prince, R. L, Eisman, J. A., Simpson, R. W. Hypercalcaemia in association with renal failure: the role of immobilisation. Aust. N Z J Med 1983: 13(1), 8–10.
Prince, R.L., Hutchison, B. G., Bhagat, C.I. Hypercalcaemia during resolution of acute renal failure associated with rhabdomyolysis: evidence for suppression of parathyroid hormone and calcitrol. Aust. N.Z.J. Med. 1986: 16(4), 506–08.
Llach, F., Felsenfeld, A. J., Haussier, M. R. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. N. Engl. J. Med. 1981: 305(3), 117–23.
Akmal, M., Bishop, J. E., Telfer, N., Norman, A. W., Massry, S. G. Hypocalcaemia and hypercalcaemia in patients with rhabdomyolysis with and without acute renal failure. J. Clin. Endocrinol Metab 1986:63(1), 137–42.
Akmal, M., Goldstein, D. A., Telfer, N., Wilkinson, E., Massry, S. G. Resolution of muscle calcification in rhabdomyolysis and acute renal failure. Ann. Intern. Med. 1978: 89, 928–30.
Torrente, A., Berl, T., Cohn, P. D., Kawamoto, E., Hertz, P., Schlier, R.W. Hypercalcaemia of acute renal failure. Am. J. Med. 1976: 61,119–23.
Miach, P. J., Dawbom, J. K., Douglas, M. E. Prolonged hypercalcaemia following acute renal failure. Ann. Int. Med. 1975: 4, 32–6,
Stewart, A. F., Adler, M., Byers, C. M., Segre, G. V., Broadus, A. E. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N. Engl. J. Med. 1982: 306(19), 1136–40.
Adami, S., Salvagno, G., Guarrera, G.et al. Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. Calcif. Tissue Int. 1986: 39, 226–29.
CanfieldV R. E., Sirris, E. S., Jacobs, T. P. Dichloromethylene diphosphonate action in hematologie and other malignancies. Bone 1987: 8(1) S57-S62.
Elomaa, I., Blomqvist, C., Porkka, L., Lamberg-Allardt, C, Borgstrom, G. H. Treatment of skeletal disease in breast cancer: a controlled clo-dronate trial. Bone 1987: 8(1), S53-S56.
Urwin, G. H., Yates, A. J. P., Gray, R. E. S.et al. Treatment of the hypercalcaemia of malignancy with intravenous clodronate. Bone 1987: 8(1), S43-S51.
Lerman, S., Canterbury, J. M., Reiss, E. Parathyroid hormone and the hypercalcaemia of immobilization. J. Clin. Endocrinol. Metab. 1977: 45, 425–28.
Gallacher, S. J., Ralston, S. H., Dryburgh, F. I.et al. Immobilization-related hypercalcaemia -a possible novel mechanism and response to pamidronate. Postgrad. Med. J. 1990: 66, 918–22.
Ludmerer, K. M., Kissane, J. M. Hypercalcaemia, renal failure and death in a 42 year old man. Am. J. Med. 1986: 81, 1019–25.
Agnholt, J., Anderson, P. T., Nielsen, L. K. Delayed hypercalcaemia after non-oliguric acute renal failure associated with rhabdomyolysis. Acta. Med. Scand. 1988: 224(1), 85–7.
Heany. R. P. Radiocalcium metabolism in disuse osteoporosis in man. Am. J. Med. 1962: 33, 188–200.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crowe, G., Spedding, R., McCance, D.R. et al. Severe hypercalcaemia four months after acute oliguric renal failure—successful treatment with intravenous clodronate. I.J.M.S. 161, 414–416 (1992). https://doi.org/10.1007/BF02996206
Issue Date:
DOI: https://doi.org/10.1007/BF02996206